Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 21 | 21 |
| 1997 | 0 | 17 | 17 |
| 1998 | 0 | 27 | 27 |
| 1999 | 0 | 30 | 30 |
| 2000 | 0 | 23 | 23 |
| 2001 | 1 | 33 | 34 |
| 2002 | 0 | 26 | 26 |
| 2003 | 0 | 33 | 33 |
| 2004 | 1 | 40 | 41 |
| 2005 | 1 | 31 | 32 |
| 2006 | 1 | 20 | 21 |
| 2007 | 1 | 43 | 44 |
| 2008 | 1 | 46 | 47 |
| 2009 | 1 | 44 | 45 |
| 2010 | 0 | 45 | 45 |
| 2011 | 0 | 38 | 38 |
| 2012 | 0 | 35 | 35 |
| 2013 | 1 | 40 | 41 |
| 2014 | 0 | 36 | 36 |
| 2015 | 1 | 30 | 31 |
| 2016 | 0 | 41 | 41 |
| 2017 | 0 | 41 | 41 |
| 2018 | 1 | 43 | 44 |
| 2019 | 1 | 44 | 45 |
| 2020 | 0 | 34 | 34 |
| 2021 | 0 | 26 | 26 |
| 2022 | 0 | 12 | 12 |
| 2023 | 0 | 15 | 15 |
| 2024 | 0 | 22 | 22 |
| 2025 | 0 | 15 | 15 |
| 2026 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial. JAMA Oncol. 2026 09 01; 12(9):980-989.
-
Neoadjuvant Stereotactic Body Radiotherapy plus Immune Therapy Favorably Remodels the Hepatocellular Carcinoma Tumor Microenvironment. Clin Cancer Res. 2026 Jul 17; 32(14):2885-2897.
-
Treatment Type and Mortality for Black Versus White Patients With Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2026 Oct; 24(7):102626.
-
The Natural History of Residual and Recurrent Disease in Advanced Juvenile Nasopharyngeal Angiofibroma: A Systematic Review. Laryngoscope. 2026 Oct; 136(10):4130-4138.
-
The 2026 American Association for Thoracic Surgery Expert Consensus Document: Evaluation and management of N2+ non-small cell lung cancer. J Thorac Cardiovasc Surg. 2026 Aug; 172(2):450-466.e2.
-
The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma. Ann Thorac Surg. 2026 07; 122(1):3-21.
-
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520834.
-
Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement. J Natl Compr Canc Netw. 2026 Mar 09; 24(5).
-
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis. Lancet. 2026 03 14; 407(10533):1059-1071.
-
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial. Clin Cancer Res. 2026 Feb 04; 32(3):479-488.